190 related articles for article (PubMed ID: 12901126)
1. Heparin-induced thrombocytopenia.
Warkentin TE
Curr Hematol Rep; 2002 Sep; 1(1):63-72. PubMed ID: 12901126
[TBL] [Abstract][Full Text] [Related]
2. Testing for heparin-induced thrombocytopenia antibodies.
Warkentin TE; Sheppard JA
Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
[TBL] [Abstract][Full Text] [Related]
3. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
[TBL] [Abstract][Full Text] [Related]
4. Newer insights on the mechanism of heparin-induced thrombocytopenia.
Walenga JM; Jeske WP; Prechel MM; Bakhos M
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():57-67. PubMed ID: 15085467
[TBL] [Abstract][Full Text] [Related]
5. Heparin-induced thrombocytopenia: some working hypotheses on pathogenesis, diagnostic strategies and treatment.
Alberio L
Curr Opin Hematol; 2008 Sep; 15(5):456-64. PubMed ID: 18695368
[TBL] [Abstract][Full Text] [Related]
6. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?
Warkentin TE; Sheppard JA; Moore JC; Moore KM; Sigouin CS; Kelton JG
J Lab Clin Med; 2005 Dec; 146(6):341-6. PubMed ID: 16310517
[TBL] [Abstract][Full Text] [Related]
7. Heparin-induced thrombocytopenia.
Warkentin TE
Hematol Oncol Clin North Am; 2007 Aug; 21(4):589-607, v. PubMed ID: 17666280
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation of heparin-induced thrombocytopenia.
Warkentin TE
Semin Hematol; 1998 Oct; 35(4 Suppl 5):9-16; discussion 35-6. PubMed ID: 9855179
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of anti-PF4/heparin antibodies and the HIT syndrome in cardiovascular medicine.
Mattioli AV
Semin Thromb Hemost; 2004 Jun; 30(3):291-5. PubMed ID: 15282651
[TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
11. When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients.
Chang JJ; Parikh CR
Semin Dial; 2006; 19(4):297-304. PubMed ID: 16893407
[TBL] [Abstract][Full Text] [Related]
12. An overview of the heparin-induced thrombocytopenia syndrome.
Warkentin TE
Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649
[TBL] [Abstract][Full Text] [Related]
13. Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?
Warkentin TE; Greinacher A; Koster A
Ann Thorac Surg; 2009 May; 87(5):1633-40. PubMed ID: 19379937
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia: diagnosis and management.
Hassell K
Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
[TBL] [Abstract][Full Text] [Related]
15. A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex.
Francis JL
Semin Thromb Hemost; 2004 Jun; 30(3):359-68. PubMed ID: 15282659
[TBL] [Abstract][Full Text] [Related]
16. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
Levy JH; Tanaka KA; Hursting MJ
Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
[TBL] [Abstract][Full Text] [Related]
17. [Anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia--review].
Lei Q; Chen L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):457-60. PubMed ID: 18426686
[TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia: an overview.
Kelton JG
Blood Rev; 2002 Mar; 16(1):77-80. PubMed ID: 11914002
[TBL] [Abstract][Full Text] [Related]
19. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
Papalambros E; Sigala F; Travlou A; Bastounis E; Mirilas P
J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
[TBL] [Abstract][Full Text] [Related]
20. Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome.
Matsuo T; Tomaru T; Kario K; Hirokawa T;
Thromb Res; 2005; 115(6):475-81. PubMed ID: 15792678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
